InVivo Therapeutics Hldgs Corp (fka NVIVQ)

[rru2s]

I did add another 15 percent to my position, and I am 100 percent convinced that NVIV is comprised of highly qualified leaders who will execute on their pipeline. Keep in mind this is a development stage biotech and to reap the rewards you have to wait until these developments happen. There is always considerable uncertainty of holding developmental biotechs - typically it can be anywhere between one week to the better half one year to see major milestones be announced, regardless of their initial projections. Meanwhile there will be sentiment improvement as the market perceives future events coming closer and closer, just like there was back with NVIV between May and July. Sentiment goes in cycles.